Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Parental Decision-Making for Children With Relapsed Neuroblastoma

ClinicalTrials.gov ID: NCT02282735

Public ClinicalTrials.gov record NCT02282735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02282735
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Dana-Farber Cancer Institute
Other
Enrollment
96 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2013
Primary completion
Mar 31, 2019
Completion
May 31, 2027
Last update posted
Jul 28, 2025

2013 – 2027

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Children's Hospital of Los Angeles Los Angeles California 90027
Stanford/Packard's Children's Hospital Palo Alto California 94304
The University of Chicago Medical Center Chicago Illinois 60637
Dana-Farber Cancer Institute Boston Massachusetts 02215
Columbia University Medical Center New York New York 10032
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
St. Jude Children's Research Hospital Memphis Tennessee 38105
Cook's Children's Healthcare System Fort Worth Texas 76104
Seattle Children's Hospital Seattle Washington 98145

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02282735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02282735 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →